Skip to content

Evalulation of Neutrophil Extracellular Traps (NETs) as prognostic markers after elective cardiac surgery

Evalulation of Neutrophil Extracellular Traps (NETs) as prognostic markers after elective cardiac surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00009850
Enrollment
80
Registered
2016-04-04
Start date
2016-04-04
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

SIRS -(systemic inflammatory Response Syndrome) and development of complications, such as Sepsis, after cardiac surgery R65

Interventions

Group 1: Patients undergoing off pump coronary artery Bypass (OPCAB) surgery will serve as control. NETs Level in the control group will be compared to those measured in patients undergoing cardiopulm

Sponsors

Herzzentrum der Universität zu KölnKlinik für Herz- und Thoraxchirurgie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Written informed consent from all participants or their legal representatives

Exclusion criteria

Exclusion criteria: - patients with known preexisting immunological disorders or systemic immunosuppressive medication -no consent -<18

Design outcomes

Primary

MeasureTime frame
Blood samples will be collected from patients undergoing cardiac surgery at the day of admission, pre-OP, post-OP as well as at days 1, 3,, 5, 8 and 10 after surgery. NETs levels in patients' Plasma will be quantified by photometry and Real Time PCR, respectively.

Secondary

MeasureTime frame
The scoring Systems CASUS, SOFA and APACHEII will be calculated. Plasma NETs level will be correlated to patients' scores

Countries

Germany

Contacts

Public ContactAdnana Paunel-Görgülü

Herzzentrum der Universität zu Köln

adnana.paunel-goerguelue@uk-koeln.de0221-478-32694

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026